Page 20 - Forbes - USA (November 2019)

LLS:

LEADING
LEADING

The Leukemia & Lymphoma Society is leading the charge
against one of the most daunting challenges in blood cancer:
acute myeloid leukemia (AML), which claims the lives of nearly
PRECISION Beat AML® Master Clinical Trial brings together the brightest
11,000 patients in the U.S. each year. Our groundbreaking

minds across the cancer landscape. Using a precision medicine

approach to treatment, patients are assigned a targeted therapy
MEDICINE. based on their genetic profile.

To bring new and better treatments to cancer patients in
urgent need, we need to think and act boldly.

Please help us by

donating today at

www.LLS.org/Donate.